Pluri

Biotechnology ResearchIsrael201-500 Employees

Pluri is a biotechnology company based in Haifa, Israel, focused on developing cell-based products for commercial use. Its flagship platform centers on a patented three-dimensional cell expansion process designed to produce cells at scale with consistent quality across batches. The company operates in regenerative medicine and food-tech and seeks partnerships to apply its mass-cell-production capabilities to other industries addressing medical needs, climate change, food scarcity, and animal welfare concerns.

Its current customers and collaborators come from regenerative medicine and related sectors seeking scalable cell-based solutions. Pluri aims to form partnerships that extend its technology into additional industries that require effective, large-volume cell production. In June 2026, its subsidiary Cellav Health and Aesthetics Ltd. announced the completion of U.S. cosmetic product listings for Regenativo+ and Placento+, signaling readiness for a U.S. commercial launch.

Sign up for free to view info

Email Format Employee directory